XB
XTL Biopharmaceuticals Ltd
🇩🇪XFRA.H2K2GermanyHealthcare
€1.99EURup +0.02 (+1.02%)OpenEnd of day3:32 PM
Price€1.99+0.02 (+1.02%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US98386D3070
- CUSIP
- Not reported
Company
- Employees
- 10
- Headquarters
- Ramat Gan, Germany
- Website
- https://www.xtlbio.com
- CEO
- Mr. Noam Band
Market
- Shares outstanding
- 2.4M
- Market cap
- €4.71M
Highlights
- Market cap
- €4.71M
- EPS LTM
- -$0.43calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $451K+100%up year on year
- Net income
- -$1.03M+42.37%up year on year
- Gross margin
- 26.39%
- Free cash flow
- Not reported
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.